Sub-healthy , low immunity people
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Hainan Medical University Lecheng Hospital (Ciming Boao International Hospita)
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-70 years old, gender is not limited; (2) People with tissue hyperplasia such as nodules, polyps, cysts and lipomas in imaging indicators; (3) Abnormal increase of tumor markers in blood; (4) Have a history of chronic infection with HBV, HPV and other viruses; (5) chronic hepatitis B and/or cirrhosis of the liver; (6) People susceptible to seasonal infectious diseases such as influenza; (7) Sub-healthy people and people with low immunity; (8) Patients need to sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Severe renal insufficiency: creatinine clearance 3 times the upper limit of normal value, or other known liver diseases such as acute and chronic active hepatitis, cirrhosis, etc.; (3) During the screening period, patients with heart failure who developed acute myocardial infarction or underwent interventional therapy within the last 6 months (III-IV patients according to NYHA classification); (4) Patients with other serious primary diseases of nervous system, heart, lung, hematopoietic system or endocrine system and mental illness; (5) Suspected or have a history of alcohol or drug abuse; (6) Pregnant women or breastfeeding women, subjects of reproductive age (including male subjects who have heterosexual sex and their female partners who have reproductive potential) from the beginning of screening to 3 months after the withdrawal of drugs have pregnancy plans or do not want to take effective contraceptive measures; (7) Have participated in other drug clinical trials within 30 days before screening, or are participating in other clinical trials; (8) The researcher considers it not suitable to participate in this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CBC;routine urine test ;blood biochemistry;ESR;CRP;ECG; | — |
Secondary
| Measure | Time frame |
|---|---|
| IFN-?+CD8+T; | — |
Countries
China
Contacts
Public ContactHuang Yuyong
The First Affiliated Hospital of Hainan Medical University Lecheng Hospital
Outcome results
None listed